Cargando…

Real-time metabolic profiling of oesophageal tumours reveals an altered metabolic phenotype to different oxygen tensions and to treatment with Pyrazinib

Oesophageal cancer is the 6th most common cause of cancer related death worldwide. The current standard of care for oesophageal adenocarcinoma (OAC) focuses on neoadjuvant therapy with chemoradiation or chemotherapy, however the 5-year survival rates remain at < 20%. To improve treatment outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buckley, Amy M., Dunne, Margaret R., Morrissey, Maria E., Kennedy, Susan A., Nolan, Aoife, Davern, Maria, Foley, Emma K., Clarke, Niamh, Lysaght, Joanne, Ravi, Narayanasamy, O’Toole, Dermot, MacCarthy, Finbar, Reynolds, John V., Kennedy, Breandán N., O’Sullivan, Jacintha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7374542/ https://www.ncbi.nlm.nih.gov/pubmed/32694701 http://dx.doi.org/10.1038/s41598-020-68777-7

Ejemplares similares

Leukaemia inhibitory factor is associated with treatment resistance in oesophageal adenocarcinoma
por: Buckley, Amy M., et al.
Publicado: (2018)

The Mitochondrial Genes BAK1, FIS1 and SFN are Linked with Alterations in Mitochondrial Membrane Potential in Barrett’s Esophagus
por: Phelan, James J., et al.
Publicado: (2018)

Effect of cigarette smoke extract on the intestinal microenvironment of ulcerative colitis tissue
por: Cannon, Aoife, et al.
Publicado: (2020)

Characterisation of an Isogenic Model of Cisplatin Resistance in Oesophageal Adenocarcinoma Cells
por: Buckley, Amy M., et al.
Publicado: (2019)

Mucosal-Associated Invariant T Cells Display Diminished Effector Capacity in Oesophageal Adenocarcinoma
por: Melo, Ashanty M., et al.
Publicado: (2019)

Impact of radiotherapy on the immune landscape in oesophageal adenocarcinoma
por: Donlon, Noel E, et al.
Publicado: (2022)

Chemotherapy regimens induce inhibitory immune checkpoint protein expression on stem-like and senescent-like oesophageal adenocarcinoma cells
por: Davern, Maria, et al.
Publicado: (2021)

Altered Mitochondrial Function and Energy Metabolism Is Associated with a Radioresistant Phenotype in Oesophageal Adenocarcinoma
por: Lynam-Lennon, Niamh, et al.
Publicado: (2014)

The Prognostic Value of the Lymph Node in Oesophageal Adenocarcinoma; Incorporating Clinicopathological and Immunological Profiling
por: Donlon, Noel E., et al.
Publicado: (2021)

The tumour microenvironment of the upper and lower gastrointestinal tract differentially influences dendritic cell maturation
por: Morrissey, Maria E., et al.
Publicado: (2020)

Visceral Adipose Tissue Modulates Radiosensitivity in Oesophageal Adenocarcinoma
por: Mongan, Ann Marie, et al.
Publicado: (2019)

Energy Metabolism, Metabolite, and Inflammatory Profiles in Human Ex Vivo Adipose Tissue Are Influenced by Obesity Status, Metabolic Dysfunction, and Treatment Regimes in Patients with Oesophageal Adenocarcinoma
por: O’Connell, Fiona, et al.
Publicado: (2023)

Potential of damage associated molecular patterns in synergising radiation and the immune response in oesophageal cancer
por: Donlon, Noel E, et al.
Publicado: (2023)

Differential Expression Profiles of Oxidative Stress Levels, 8-oxo-dG and 4-HNE, in Barrett’s Esophagus Compared to Esophageal Adenocarcinoma
por: O’Farrell, Naoimh J., et al.
Publicado: (2019)

Faster Evolving Primate Genes Are More Likely to Duplicate
por: O’Toole, Áine N, et al.
Publicado: (2018)

Combining 1,4-dihydroxy quininib with Bevacizumab/FOLFOX alters angiogenic and inflammatory secretions in ex vivo colorectal tumors
por: Kennedy, Susan A., et al.
Publicado: (2020)

PD-1 blockade enhances chemotherapy toxicity in oesophageal adenocarcinoma
por: Davern, Maria, et al.
Publicado: (2022)

Acidosis significantly alters immune checkpoint expression profiles of T cells from oesophageal adenocarcinoma patients
por: Davern, Maria, et al.
Publicado: (2022)

Visceral adipose tissue secretome from early and late-stage oesophageal cancer patients differentially affects effector and regulatory T cells
por: Davern, Maria, et al.
Publicado: (2023)

1,4-dihydroxy quininib attenuates growth of colorectal cancer cells and xenografts and regulates the TIE-2 signaling pathway in patient tumours
por: Butler, Clare T., et al.
Publicado: (2019)

FLOT and CROSS chemotherapy regimens alter the frequency of CD27(+) and CD69(+) T cells in oesophagogastric adenocarcinomas: implications for combination with immunotherapy
por: Davern, Maria, et al.
Publicado: (2022)

Excess visceral adiposity induces alterations in mitochondrial function and energy metabolism in esophageal adenocarcinoma
por: Lynam-Lennon, Niamh, et al.
Publicado: (2014)

Evaluation of Cysteinyl Leukotriene Signaling as a Therapeutic Target for Colorectal Cancer
por: Burke, Lorraine, et al.
Publicado: (2016)

Linking Circulating Serum Proteins with Clinical Outcomes in Esophageal Adenocarcinoma—An Emerging Role for Chemokines
por: Donlon, Noel E., et al.
Publicado: (2020)

Cooperation between chemotherapy and immune checkpoint blockade to enhance anti-tumour T cell immunity in oesophageal adenocarcinoma
por: Davern, Maria, et al.
Publicado: (2022)

Opposing Immune-Metabolic Signature in Visceral Versus Subcutaneous Adipose Tissue in Patients with Adenocarcinoma of the Oesophagus and the Oesophagogastric Junction
por: Heeran, Aisling B., et al.
Publicado: (2021)

The future of combination immunotherapy in oesophageal adenocarcinoma
por: Davern, Maria, et al.
Publicado: (2023)

The Protein Secretome Is Altered in Rectal Cancer Tissue Compared to Normal Rectal Tissue, and Alterations in the Secretome Induce Enhanced Innate Immune Responses
por: Heeran, Aisling B., et al.
Publicado: (2021)

Energy Metabolism Is Altered in Radioresistant Rectal Cancer
por: Buckley, Croí E., et al.
Publicado: (2023)

The Impact of Esophageal Oncological Surgery on Perioperative Immune Function; Implications for Adjuvant Immune Checkpoint Inhibition
por: Donlon, Noel E., et al.
Publicado: (2022)

Targeting cancer-cell mitochondria and metabolism to improve radiotherapy response
por: McCann, Emma, et al.
Publicado: (2020)

Preclinical validation of the small molecule drug quininib as a novel therapeutic for colorectal cancer
por: Murphy, Adrian G., et al.
Publicado: (2016)

Impact of Fatigue in Rheumatic Diseases in the Work Environment: A Qualitative Study
por: Connolly, Deirdre, et al.
Publicado: (2015)

Colonic oncostatin M expression evaluated by immunohistochemistry and infliximab therapy outcome in corticosteroid-refractory acute severe ulcerative colitis
por: O’Connell, Jim, et al.
Publicado: (2022)

The Role of Mitochondria in Optic Atrophy With Autosomal Inheritance
por: Strachan, Elin L., et al.
Publicado: (2021)

Absorbance Based Light Emitting Diode Optical Sensors and Sensing Devices
por: O'Toole, Martina, et al.
Publicado: (2008)

Investigating the susceptibility of treatment-resistant oesophageal tumours to natural killer cell-mediated responses
por: Mylod, Eimear, et al.
Publicado: (2022)

Comparison of risk scoring systems for critical care patients with upper gastrointestinal bleeding: predicting mortality and length of stay
por: Lincoln, Marc, et al.
Publicado: (2022)

Diagnosis and Management of Upper Gastrointestinal Neuroendocrine Tumors
por: Chin, Jun Liong, et al.
Publicado: (2017)

Metformin is a metabolic modulator and radiosensitiser in rectal cancer
por: Buckley, Croí E., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_blhr8sptkrkqmvg7blph1572nc